Nanomedicine and Nanotechnology

Welcome Message

We are pleased to welcome nanomedicine researchers, nanotechnology scientists, biomedical engineers, clinicians, healthcare professionals, academics, researchers, pharmaceutical experts, and industry leaders to the 10th International Conference on Nanomedicine and Nanotechnology, taking place on March 22–23, 2027, in Rome, Italy. With the theme “Advancing Nanomedicine Through Innovation, Precision, and Next-Generation Nanotechnologies,” this international forum brings together experts and professionals to exchange scientific knowledge, discuss emerging innovations, and share advancements in nanomedicine, nanomaterials, drug delivery, nanodiagnostics, cancer nanotechnology, biomedical nanotechnology, nano-biosensors, targeted therapies, and precision medicine. The conference aims to encourage meaningful scientific discussions, foster interdisciplinary collaborations, and explore the potential of advanced nanotechnology in transforming modern medicine and healthcare. It provides a valuable platform to present research findings, examine next-generation technologies, and discuss innovative approaches for improving disease diagnosis, targeted treatment, drug delivery, and patient care.

We look forward to your valuable participation in Rome, Italy, on March 22–23, 2027, and to creating a productive environment for knowledge exchange, scientific networking, innovation, and global collaboration in nanomedicine and nanotechnology.

Target Audience:

•  Nanomedicine Researchers
• Nanotechnology Scientist
• Nanoscience Researchers
• Biomedical Enginee
• Pharmaceutical Scientists
• Drug Delivery Researcher
• Nanomaterials Scientist
• Biomedical Scientists
• Molecular Biologists
• Biotechnology Professionals
• Medical Researchers
• Clinicians and Physicians
• Cancer Researchers and Oncologists
• Nanodiagnostics Specialists
• Nano-Biosensor Researchers
• Precision Medicine Researchers
• Regenerative Medicine Scientists
• Tissue Engineering Researchers
• Pharmacologists
• Clinical Pharmacologists
• Drug Development Scientist
• Medical Device Professionals   
•  Academicians and Professors

About Conference

The 10th International Conference on Nanomedicine and Nanotechnology, taking place on March 22–23, 2027, in Rome, Italy, is designed as a global platform for nanomedicine researchers, nanotechnology scientists, biomedical engineers, clinicians, pharmaceutical experts, academics, healthcare professionals, and industry leaders to exchange knowledge and explore recent advancements in nanoscience and its medical applications. Under the theme “Advancing Nanomedicine Through Innovation, Precision, and Next-Generation Nanotechnologies,” the conference will highlight emerging developments in nanomedicine, nanomaterials, drug delivery, nanodiagnostics, cancer nanotechnology, nano-biosensors, targeted therapies, biomedical nanotechnology, and precision medicine. The conference will provide opportunities to present research findings, discuss innovative technologies, explore emerging therapeutic strategies, and examine the role of nanotechnology in improving disease diagnosis and treatment. Through keynote lectures, scientific sessions, interactive discussions, workshops, and expert presentations, participants can gain insights into current research and future directions in nanomedicine and nanotechnology.

We invite professionals and researchers from around the world to participate in this scientific forum in Rome, Italy, on March 22–23, 2027, and contribute to advancing innovation, research, collaboration, and next-generation healthcare through nanotechnology.

Featured at the 10th International Conference on Nanomedicine and Nanotechnology

• Expert Keynotes: Insights from leading experts on emerging developments in nanomedicine and nanotechnology.
• Scientific Sessions: Presentations on recent research, discoveries, technologies, and therapeutic applications.
• Interactive Workshops: Practical learning focused on advanced nanomaterials, nano-drug delivery, diagnostics, and biomedical applications.
• Specialized Discussions: Focus on targeted therapies, cancer nanotechnology, nanodiagnostics, nano-biosensors, and precision medicine.
• Networking: Connect with researchers, clinicians, academicians, industry professionals, and technology innovators worldwide.
• Panel Discussions: Explore emerging trends, challenges, opportunities, and future directions in nanomedicine and nanotechnology.

Why to Attend:

Attending the 10th International Conference on Nanomedicine and Nanotechnology offers an opportunity to explore the latest research, innovations, and technological advances shaping the future of medicine. The conference brings together nanotechnology scientists, nanomedicine researchers, biomedical engineers, pharmaceutical experts, clinicians, academicians, and industry professionals to exchange knowledge and research experiences. Participants can gain valuable insights into nanomaterials, targeted drug delivery, nanodiagnostics, cancer nanotechnology, nano-biosensors, biomedical applications, precision medicine, and emerging therapeutic technologies. The event provides a platform to discuss innovative approaches, explore interdisciplinary research opportunities, and understand how next-generation nanotechnologies can contribute to improved diagnosis, treatment, and healthcare outcomes.By attending, participants can expand their scientific knowledge, discover emerging technologies, strengthen professional networks, establish research collaborations, and contribute to the advancement of nanomedicine and nanotechnology.

Sessions and Tracks

Track 1: Nanomedicine and Biomedical Nanotechnology

Nanomedicine applies nanoscale science and engineering to the prevention, diagnosis, monitoring, and treatment of diseases. Engineered nanomaterials, nanoscale systems, and multifunctional platforms are being developed for a wide range of biomedical applications. Key areas include interactions between nanomaterials and biological systems, therapeutic innovations, and the translation of laboratory discoveries into healthcare solutions. Emerging applications in diagnostics, targeted therapies, regenerative medicine, and personalized healthcare will also be highlighted.

• Biomedical nanotechnology
• Nanomedicine applications
• Therapeutic nanomaterials
• Nanoscale biomedical systems
• Translational nanomedicine
• Emerging healthcare nanotechnologies

Track 2: Nanomaterials and Nanostructures

Nanomaterials form the foundation of many modern nanotechnology and nanomedicine applications. Research focuses on the design, synthesis, characterization, modification, and biomedical utilization of advanced nanoscale materials. Material properties such as size, morphology, surface chemistry, stability, and biocompatibility can strongly influence biological performance. Recent developments in multifunctional and application-specific nanostructures will be explored.

• Nanomaterial synthesis
• Nanostructured materials
• Metallic and metal oxide nanoparticles
• Polymeric nanomaterials
• Carbon-based nanomaterials
• Nanomaterial characterization

Track 3: Nanoparticles and Nanoformulations

Nanoparticles provide versatile platforms for delivering therapeutic and diagnostic agents. Research encompasses the development of nanoparticles with controlled size, morphology, surface characteristics, stability, and biological activity. Particular emphasis is placed on formulation optimization, cellular uptake, bioavailability, and multifunctional nanoformulations for medical applications. Novel approaches to nanoparticle engineering and therapeutic delivery will also be discussed.

• Nanoparticle design
• Surface functionalization
• Nanoformulations
• Biocompatible nanoparticles
• Nanoparticle stability
• Biological interactions of nanoparticles

Track 4: Nanotechnology in Drug Delivery

Nanotechnology is enabling more precise and controlled approaches to drug delivery. Nano-enabled delivery systems can improve drug solubility, stability, bioavailability, circulation, and therapeutic performance. Research includes controlled-release technologies, targeted delivery, smart nanocarriers, and approaches for transporting therapeutic molecules to specific tissues or cells. Advances in site-specific and personalized drug delivery will also be explored.

• Targeted drug delivery
• Controlled and sustained release
• Nanocarriers
• Liposomes and polymeric nanoparticles
• Drug encapsulation
• Site-specific delivery systems

Track 5: Cancer Nanotechnology and Nanotherapeutics

Cancer nanotechnology applies nanoscale technologies to improve cancer detection, diagnosis, imaging, and treatment. Current research includes targeted nanomedicines, tumor-specific delivery systems, nano-enabled imaging, combination therapies, and strategies designed to improve therapeutic selectivity. Emerging nanotherapeutic approaches may support more precise and personalized cancer care while addressing challenges associated with conventional treatments.

• Cancer nanomedicine
• Targeted cancer therapy
• Nanoparticle-based therapeutics
• Tumor-targeted drug delivery
• Nano-enabled cancer imaging
• Combination nanotherapies

Track 6: Nanodiagnostics and Nano-Biosensors

Nanotechnology is contributing to the development of highly sensitive and rapid diagnostic technologies. Nanoscale biosensors and molecular detection systems can support the identification of biomarkers and disease-associated signals. Research will cover advances in sensor design, signal detection, point-of-care technologies, and integration of nanomaterials into next-generation diagnostic platforms. Applications in early disease detection and real-time monitoring will also be considered.

• Nano-biosensors
• Molecular diagnostics
• Biomarker detection
• Point-of-care diagnostics
• Nanodiagnostic platforms
• Electrochemical and optical nanosensors

Track 7: Nanotechnology in Imaging and Theranostics

Nanotechnology can combine diagnostic and therapeutic capabilities within multifunctional platforms. Nanomaterial-based imaging agents, molecular imaging systems, targeted nanosystems, and theranostic platforms offer opportunities for integrating disease detection, monitoring, and treatment. Research will explore image-guided therapies, multifunctional nanoparticles, and emerging approaches supporting personalized diagnosis and therapeutic decision-making.

• Nanoparticle-based imaging
• Molecular imaging
• Theranostic nanoplatforms
• Imaging-guided therapy
• Multifunctional nanoparticles
• Personalized nanomedicine

Track 8: Nanopharmaceuticals and Pharmaceutical Nanotechnology

Pharmaceutical nanotechnology applies nanoscale technologies to improve the formulation, delivery, stability, and performance of therapeutic products. Research encompasses nanopharmaceutical development, nanoformulation strategies, drug solubility enhancement, and nano-enabled therapeutics. Important considerations include formulation optimization, pharmaceutical characterization, manufacturing, quality assessment, and the translation of nanoscale formulations into therapeutic applications.

• Nanopharmaceutical formulations
• Nano-enabled therapeutics
• Pharmaceutical nanotechnology
• Drug solubility enhancement
• Nanoformulation development
• Pharmaceutical characterization

Track 9: Nanotoxicology and Safety Assessment

Understanding the biological safety of nanomaterials is essential for their responsible development and application. Research examines how nanoparticles interact with cells, tissues, and biological systems and investigates potential toxicity mechanisms and exposure-related considerations. Safety evaluation approaches include in vitro and in vivo studies, biocompatibility assessment, risk characterization, and evaluation of nano-enabled medical products.

• Nanotoxicology
• Nanomaterial-biological interactions
• Cellular toxicity
•  In vivo and in vitro safety assessment
• Nanomaterial exposure
• Risk assessment

Track 10: Nano-Bio Interfaces and Nanobiotechnology

Interactions between nanomaterials and biological systems are central to the development of many biomedical technologies. Research encompasses nano-bio interfaces, cellular interactions, biomolecular recognition, biofunctionalization, and nanoscale biological systems. Integrating biological principles with nanotechnology can support the development of innovative biomedical platforms, therapeutic systems, biosensors, and diagnostic technologies.

• Nano-bio interfaces
• Nanobiotechnology
• Cellular-nanomaterial interactions
• Biomolecular recognition
• Biological nanostructures

Track 11: Nanotechnology in Regenerative Medicine

Nanotechnology provides new approaches for tissue repair and regeneration through engineered scaffolds, nanofibers, and bioactive nanomaterials. Nanoscale structures can influence cellular behaviour, tissue organization, adhesion, proliferation, and regenerative processes. Research includes nanostructured biomaterials, tissue engineering platforms, regenerative nanomedicine, and the development of functional materials for tissue repair.

• Nanostructured scaffolds
• Tissue engineering
•  Nanofibers
• Regenerative nanomedicine
• Cell-material interactions
• Bioactive nanomaterials

Track 12: Nanotechnology in Gene and RNA Delivery

Nanoscale delivery systems are being developed to transport nucleic acids and genetic therapeutics into specific cells and tissues. Research focuses on nanocarriers for gene and RNA delivery, cellular uptake, intracellular release, stability, and delivery efficiency. Emerging applications involving siRNA, mRNA, and other nucleic-acid-based therapeutics will be explored alongside advances in nanoparticle-mediated delivery systems.

• Gene delivery systems
• RNA delivery
• Nucleic acid nanocarriers
• siRNA and mRNA delivery
• Nanoparticle-mediated transfection
• Genetic therapeutics

Track 13: Nanotechnology for Precision Medicine

Precision medicine aims to develop healthcare approaches tailored to individual biological characteristics. Nanotechnology can support targeted diagnosis, biomarker detection, personalized drug delivery, and patient-specific treatment strategies. Research will explore multifunctional nanosystems, molecular targeting, precision therapeutics, and emerging approaches designed to improve treatment specificity and individualized healthcare.

• Precision nanomedicine
• Personalized drug delivery
• Molecular targeting
• Biomarker-based therapy
• Patient-specific nanotherapeutics
• Individualized treatment strategies

Track 14: Nanotechnology in Neuromedicine

Nanotechnology offers promising approaches for addressing challenges in neurological diagnosis and treatment, including targeted delivery to the nervous system. Research encompasses nanoscale technologies for neurological disorders, brain-targeted drug delivery, neural imaging, neuroregeneration, and therapeutic development. Particular attention will be given to approaches for overcoming biological barriers and improving the delivery of therapeutic agents to the brain.

• Nanomedicine for neurological disorders
• Brain-targeted drug delivery
• Nanotechnology and the blood-brain barrier
• Neural imaging
• Neuroregenerative nanotechnology
• Nanotherapeutics for brain diseases

Track 15: Nanotechnology in Cardiovascular Medicine

Nano-enabled technologies are being investigated for cardiovascular diagnosis, imaging, targeted therapy, and tissue regeneration. Nanoscale systems can support disease detection and targeted delivery of therapeutic agents to cardiovascular tissues. Research will cover cardiovascular nanomedicine, vascular applications, cardiac imaging, targeted cardiovascular therapies, and emerging nanotechnology-based approaches for cardiac regeneration.

• Cardiovascular nanomedicine
• Targeted cardiovascular therapy
• Nano-enabled imaging
• Nanoparticles for cardiovascular applications
• Vascular nanotechnology
• Nanotechnology in cardiac regeneration

Track 16: Green Nanotechnology and Sustainable Nanomaterials

Green nanotechnology promotes the development of nanoscale materials and processes with greater consideration for environmental sustainability and responsible manufacturing. Research includes environmentally conscious synthesis methods, biological production of nanoparticles, sustainable nanomaterials, and approaches for reducing environmental impact. The relationship between sustainability, safety, resource efficiency, and future nanotechnology development will also be explored.

• Green synthesis of nanoparticles
• Sustainable nanomaterials
• Biogenic nanoparticles
• Eco-friendly nanotechnology
• Sustainable nanomanufacturing
• Environmental considerations

Track 17: Computational Nanotechnology and AI in Nanomedicine

Computational approaches and artificial intelligence are increasingly being used to support nanomaterial design, prediction, analysis, and biomedical research. Machine learning, computational modeling, molecular simulation, and data-driven approaches can help optimize nanoscale therapeutic systems and accelerate research. AI-assisted nanomedicine also offers opportunities for predictive analysis, personalized treatment strategies, and improved drug delivery design.

• Artificial intelligence in nanomedicine
• Machine learning and nanotechnology
• Computational nanomaterials
• Molecular modeling
• Data-driven drug delivery
• AI-assisted nanomedicine

Track 18: Nanofabrication and Nanoengineering       

Nanoengineering enables the controlled design, fabrication, and modification of structures and devices at the nanoscale. Advanced fabrication techniques, nanoscale patterning, surface engineering, and precision manufacturing are important for developing nano-enabled biomedical technologies. Research will explore how nanoengineering approaches can support diagnostic platforms, medical devices, therapeutic systems, and next-generation nanotechnologies.

• Nanoengineering
• Nanofabrication techniques
• Nanoscale patterning
• Surface engineering

Track 19: Nanoelectronics and Nanodevices for Healthcare

The integration of nanotechnology with electronics is creating new opportunities for medical sensing, diagnostics, monitoring, and wearable healthcare technologies. Research includes nanoscale electronic devices, flexible sensors, nanoelectronic biosensors, and healthcare monitoring systems. Emerging technologies for continuous monitoring, rapid detection, and data-driven healthcare will also be explored.

• Nanoelectronic biosensors
• Nanoscale medical devices
• Wearable nanotechnology
•  Flexible nanosensors
• Healthcare monitoring systems
• Nano-enabled diagnostic devices

Track 20: Clinical Translation and Regulatory Aspects of Nanomedicine

Translating nanomedicine discoveries from laboratory research into clinical applications requires careful consideration of safety, quality, manufacturing, standardization, and regulatory requirements. Research and discussion will address clinical development, characterization, scale-up, quality control, clinical evaluation, and commercialization of nano-enabled medical products. Regulatory challenges and strategies for responsible clinical translation will also be examined.

• Clinical translation of nanomedicine
• Regulatory considerations
• Nanomedicine clinical trials
• Quality and characterization
• Standardization of nanomaterials
•  Manufacturing and scale-up

Track 21: Emerging Trends and Future Directions in Nanomedicine

Emerging research areas, innovative technologies, and new scientific approaches are continually shaping the future of nanomedicine and nanotechnology. Key developments include next-generation nanotherapeutics, multifunctional nanoplatforms, advanced diagnostics, innovative nanomaterials, and interdisciplinary healthcare technologies. Future opportunities for precision healthcare, intelligent therapeutic systems, and advanced nano-diagnostics will also be explored.

• Next-generation nanomedicine
• Emerging nanotherapeutics
• Multifunctional nanoplatformsa
• Advanced nano-diagnostics
• Future healthcare technologies
• Interdisciplinary nanotechnology research

Market Analysis

The global nanomedicine and nanotechnology market is growing steadily, driven by increasing demand for targeted drug delivery, precision medicine, advanced diagnostics, and innovative healthcare technologies. Rising investments in nanotechnology research, growing chronic disease burden, and advancements in nanomaterials are further supporting market expansion worldwide. Innovations such as nanoparticle-based drug delivery, nano-enabled imaging, biosensors, and personalized nanomedicine are improving treatment precision and early disease detection. The following graphs illustrate the market growth and key factors driving this upward trend.

Global Nanomedicine and Nanotechnology Market Growth (2024–2033)

This line graph shows the steady growth of the global nanomedicine and nanotechnology market from 2024 to 2033, reflecting increasing adoption of targeted therapies, nanodiagnostics, precision medicine, and advanced nanotechnology applications.

Key Factors Driving the Nanomedicine and Nanotechnology Market

This bar graph illustrates the major factors contributing to market growth, including targeted drug delivery, advancements in nanomaterials, nanodiagnostics, research and development investments, and the growing adoption of precision medicine

Past Conference

We sincerely appreciate all Keynote Speakers, Speakers, Participants, Students, Researchers, Organizing Committee Members, Associations, and Media Partners for their valuable contribution to the success of the 9th International Conference on Nanomedicine and Nanotechnology. The previous conference provided an excellent platform for researchers, healthcare professionals, academicians, and industry experts to exchange knowledge, present research, and discuss emerging developments in nanomedicine and nanotechnology.

We thank our Organizing Committee and participants for their continued support and valuable feedback. Building on this success, we are pleased to welcome you to the 10th International Conference on Nanomedicine and Nanotechnology, taking place on March 22–23, 2027, in Rome, Italy, for another enriching scientific gathering.a

Benefits of Participation

The 10th International Conference on Nanomedicine and Nanotechnology provides an international platform for researchers, healthcare professionals, academicians, students, and industry experts to exchange knowledge, present scientific research, and explore emerging developments in nanomedicine and nanotechnology. The conference encourages scientific interaction, research collaboration, innovation, and professional networking.

• Keynote Speaker: 45–50 minutes
• Oral Speaker: 25–30 minutes; one presenter per presentation
• Workshop Speaker: 45–50 minutes; multiple presenters may participate
• Special Session Speaker: 45–50 minutes; multiple presenters may participate
• Symposium Speaker: More than 45 minutes; multiple presenters may participate
• Delegate: Registration-only participation with access to scientific sessions and conference benefits
• Poster Presenter: Opportunity to present research and receive delegate benefits
• Remote Participant: Participation through video presentation or e-poster presentation
• Media Partner
• Sponsor
• Collaborator

Advantages of participating:

• Receive an International Speaker or Participant Certificate.
• Gain international visibility for research and professional expertise.
• Exchange knowledge with leading experts in nanomedicine and nanotechnology.
• Explore recent research, technologies, applications, and innovations.
• Develop valuable academic, scientific, and industry collaborations.
• Participate in keynote presentations, workshops, scientific sessions, and networking activities.
• Opportunity to receive Young Researcher and Best Poster recognition

Benefits of speakers:

• Present research, innovations, and scientific findings to an international audience.
• Receive a Speaker Participation Certificate.
• Enhance professional and research visibility.
• Exchange ideas and receive feedback from experts.
• Explore emerging trends and applications in nanomedicine and nanotechnology.
• Build academic, scientific, and industry collaborations.

Benefits for Delegates:

• Discover recent advances in nanomedicine, nanotechnology, and biomedical applications.
• Gain insights from experienced researchers, clinicians, academicians, and industry experts.
• Exchange scientific knowledge with professionals from diverse backgrounds.
• Strengthen professional knowledge through presentations and interactive discussions.
• Receive a certificate recognizing conference participation.

Benefits for poster presentation:

• Present original research, innovations, and scientific findings to an international audience.
• Discuss research ideas with researchers, academicians, and industry specialists.
• Receive valuable perspectives to support further research development.
• Increase the professional visibility of scientific work.
• Gain recognition through opportunities such as Best Poster Presentation Awards.

Benefits for students and young researchers:

• Become familiar with emerging research and technological developments in nanomedicine and nanotechnology.
• Learn directly from experienced researchers and industry professionals.
• Improve scientific communication, presentation, and networking skills.
• Explore opportunities for research partnerships and academic development.
• Interact with international peers and established professionals.
• Gain confidence and recognition by presenting innovative research.

Benefits for sponsors:

• Showcase products, services, technologies, and innovations to an international audience.
• Increase brand visibility and reach potential business partners.
• Connect with researchers, healthcare professionals, academicians, and industry experts.
• Explore new partnerships, collaborations, and business opportunities.

Benefits for collaborators:

• Increase organizational visibility through an international scientific platform.
• Connect with researchers, academicians, healthcare professionals, and industry representatives.
• Promote organizational activities, services, and initiatives.
• Build professional relationships and explore future collaborations.

Abstract Submission &Visa Guidelines

Abstract submission guidelines:

• Submit your abstract through the official Abstract Submission Portal.
• Abstracts must be in English (250–300 words) with a 100–120-word presenter biography.
• Original research, experimental studies, reviews, case studies, and innovative work related to nanomedicine and nanotechnology are welcome.
• Include the presenter’s name, affiliation, country, email, contact details, and photograph.
• List all co-authors with their institutional affiliations.
• All submissions will be reviewed by the Scientific Review Committee.
• Accepted presenters must complete registration to confirm participation.
• Ensure all submitted information is accurate for inclusion in the conference program and proceedings.

Visa Guidelines

Planning to Attend the 10th International Conference on Nanomedicine and Nanotechnology?

We welcome international participants and provide necessary documentation to support the visa application process. Registered participants may receive the following documents:

• Official Invitation Letter for visa purposes
• Abstract Acceptance Letter for presenters
• Registration Confirmation and Payment Receipt

Important information:

• Visa support documents are issued only after successful registration and payment confirmation.
• Participants are responsible for submitting their visa applications to the appropriate embassy or consulate.
• Visa approval is subject to the decision of the respective immigration authorities.
• Visa assistance is available only to registered conference participants.

Requesting a visa offer letter:

Participants who require a visa support letter may contact the Conference Program Manager at the official conference email address [email protected].

Please provide:

• Full name as stated in the passport
• Passport number and date of birth
• Conference registration details
• Proof of registration and payment
• Country of residence